Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.
This article is protected by copyright. All rights reserved.
PMID: 30821848 [PubMed - as supplied by publisher]
Source: Clinical and Developmental Immunology - Category: Allergy & Immunology Authors: Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T Tags: Clin Exp Immunol Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Immunotherapy | Melanoma | Skin Cancer | Study | Yervoy